Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: The 10-year experience of a single center

Hematology

Volumn 16, Issue 2, 2011, Pages 73-79

  Kim, Ji Won ^a   Kim, Inho ^a   Oh, Kook Hwan ^a   Yoon, Sung Soo ^a   Oh, Myoung Don ^a   Song, Yeong Wook ^a   Heo, Dae Seog ^a   Bang, Yung Jue ^a   Han, Kyou Sup ^a   Han, Jin Suk ^a   Park, Seonyang ^a   Kim, Byoung Kook ^a  

^a Seoul National University   (South Korea)

Author keywords

Hemolytic uremic syndrome; Therapeutic plasma exchange; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura

Indexed keywords

CALCIUM;

ABDOMINAL DISCOMFORT; ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPNEA; FEMALE; HEART PALPITATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARESTHESIA; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MALE; MIDDLE AGED; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952668974     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453311X12902908411995     Document Type: Article

References (30)

1. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine 1966;45:139-59.
2. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991;325:393-7.
3. Lara PN, Jr, Coe TL, Zhou H, Fernando L, Holland PV, Wun T. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome. Am J Med 1999;107:573-9.
4. von Baeyer H. Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies. Ther Apher 2002;6:320-8.
5. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600.
6. Kojouri K, Vesely S, George JN. Quinine-associated thrombotic thrombocytopenic purpura - hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med 2001;135:1047-51. (Pubitemid 33151026)
7. Raife TJ, Lentz SR, Atkinson BS, Vesely SK, Hessner MJ. Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood 2002;99:437-42. (Pubitemid 34533076)
8. McMinn JR, George JN. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura - hemolytic uremic syndrome during pregnancy. J Clin Apheresis 2001;16:202-9. (Pubitemid 34037610)
9. Vesely SK, George JN, Lämmle B, Studt JD, Alberio L, El-Harake MA, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura - hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003;102:60-8. (Pubitemid 36759636)
10. George JN. How I treat patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome. Blood 2000;96:1223-9. (Pubitemid 30658447)
11. Vesely SK, Li X, McMinn JR, Terrell DR, George JN. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura - hemolytic uremic syndrome. Transfusion 2004;44:1149-58. (Pubitemid 38989747)
12. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, et al. Cancer-associated hemolytic - uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989;7:781-9. (Pubitemid 19145601)
13. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005;365:1073-86.
14. Kojouri K, George JN. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol 2007;19:148-54. (Pubitemid 46204355)
15. Medina PJ, Sipols JM, George JN. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 2001;8:286-93. (Pubitemid 32826498)
16. Rose M, Rowe JM, Eldor A. The changing course of thrombotic thrombocytopenic purpura and modern therapy. Blood Rev 1993;7:94-103. (Pubitemid 23237682)
17. Wyllie BF, Garg AX, Macnab J, Rock GA, Clark WF. Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange. Br J Haematol 2006;132:204-9. (Pubitemid 43381554)
18. Dervenoulas J, Tsirigotis P, Bollas G, Pappa V, Xiros N, Economopoulos T, et al. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases. Ann Hematol 2000;79:66-72. (Pubitemid 30157716)
19. Pene F, Vigneau C, Auburtin M, Moreau D, Zahar JR, Coste J, et al. Outcome of severe adult thrombotic microangiopathies in the intensive care unit. Intensive Care Med 2005;31:71-8. (Pubitemid 40174284)
20. Altuntas F, Aydogdu I, Kabukcu S, Kocyigit I, Cikim K, Sari I, et al. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study. Transfus Apher Sci 2007;36:57-67. (Pubitemid 46341964)
21. Teruya J, Styler M, Verde S, Topolsky D, Crilley P. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation. J Clin Apher 2001;16:169-74. (Pubitemid 34037605)
22. Hahn T, Alam AR, Lawrence D, Ford L, BaerMR, Bambach B, et al. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion. Transplantation 2004;78:1515-22. (Pubitemid 39552939)
23. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006;354:1927-35. (Pubitemid 43872694)
24. Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, et al. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Am J Hematol 2006;81:525-31.
25. Cohen H, Bull HA, Seddon A, Enayat MS, Hill FG, Woolf N, et al. Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation. Eur J Haematol 1989;43:207-14. (Pubitemid 19252202)
26. Batts ED, Lazarus HM. Diagnosis and treatment of transplantation- associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant 2007;40:709-19.
27. Chang JC, Naqvi T. Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. Oncologist 2003;8:375-80. (Pubitemid 36929722)
28. Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, Yarnold PR, Kwaan HC, Green D. Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60 cases. Ann Int Med 1998;128:541-4. (Pubitemid 28177661)
29. Bennett CL, Davidson CJ, Raisch DW, Weinberg PD, Bennett RH, Feldman MD. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention. Arch Intern Med 1999;159:2524-8.
30. Cantrell JE, Phillips TM, Schein PS. Carcinoma-associated hemolytic - uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol 1985;3:723-34. (Pubitemid 15119245)